α-Lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis
- 1 March 2004
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 148 (1-2) , 146-153
- https://doi.org/10.1016/j.jneuroim.2003.11.021
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Plasma Kinetics, Metabolism, and Urinary Excretion of Alpha‐Lipoic Acid following Oral Administration in Healthy VolunteersThe Journal of Clinical Pharmacology, 2003
- Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosisNature, 2003
- Compensation mechanism in tumor cell migrationThe Journal of cell biology, 2003
- α‐Lipoic acid inhibits TNF‐a‐induced NF‐κB activation and adhesion molecule expression in human aortic endothelial cellsThe FASEB Journal, 2001
- Electrically active axons degenerate when exposed to nitric oxideAnnals of Neurology, 2001
- Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator?Immunology Today, 1998
- Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitorsAnnals of Neurology, 1998
- Neuroprotection by the Metabolic Antioxidant α-Lipoic AcidFree Radical Biology & Medicine, 1997
- Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous SystemCell, 1996
- Lipoic Acid Improves Nerve Blood Flow, Reduces Oxidative Stress, and Improves Distal Nerve Conduction in Experimental Diabetic NeuropathyDiabetes Care, 1995